| Description | Eflapegrastim, a humanized IgG4 monoclonal antibody and granulocyte colony-stimulating factor (G-CSF), targets the G-CSF receptor (c-Fms). It promotes the proliferation and differentiation of neutrophil progenitor cells, ensuring a stable count of mature and functional neutrophils, and effectively shortens the duration of neutropenia [1]. |
| molecular weight | N/A |
| CAS | 1384099-30-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |